Isodiol International Inc. (ISOLF)

OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Feb 27, 2026
0.00%
Market Cap 129.00
Revenue (ttm) 12.18M
Net Income (ttm) -78.75M
Shares Out 128.53M
EPS (ttm) -1.68
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,564
Average Volume 88,550
Open 0.0000
Previous Close 0.0001
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0001
Beta -208.25
RSI 47.52
Earnings Date n/a

About Isodiol International

Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufa... [Read more]

Sector Healthcare
CEO Marcos Agramont
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol ISOLF
Full Company Profile

Financial Performance

In fiscal year 2019, Isodiol International's revenue was 22.25 million, an increase of 16.26% compared to the previous year's 19.14 million. Losses were -125.91 million, 249.6% more than in 2018.

Financial numbers in CAD Financial Statements

News

There is no news available yet.